Objective: The therapeutic benefit of inhaled corticoids in bronchiectasis not due to cystic fibrosis is still not well documented. The aim of the present study was to assess the efficacy and safety of inhaled corticoids in this disease.
Setting: This study was conducted at a tertiary university hospital in the city of Barcelona, Catalonia, (Spain).